share_log

EF Hutton Reiterates Buy on Ocean Biomedical, Maintains $10 Price Target

Benzinga ·  Apr 13, 2023 13:23

EF Hutton analyst Michael King reiterates Ocean Biomedical (NASDAQ:OCEA) with a Buy and maintains $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment